Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Refeyn
Refeyn
Activities:
Manufacturing
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Analysis
Refeyn announces appointment of Fiona Coats as Chief Marketing Officer
Fiona comes from Sartorius, and will drive the company's growth and solidify its market position
Analysis
Refeyn strengthens capability with new US Headquarters in Boston area
The novel US headquarters will expand the company's global footprint, and coincides with the annual Mass Photometry Summit in Boston
Analysis
Refeyn expands the analytical possibilities for high concentration samples by MassFluidix HC
New microfluidic system enhances protein analysis workflows for the study of weak protein-protein interactions by mass photometry
Manufacturing
Refeyn expands into AAV-based gene therapy manufacturing with GMP software
The manufacturer has deployed its new mass photometers, optimised for AAV analytics to provide accurate measurements of empty:full AAV ratios
Manufacturing
Refeyn launches SamuxMP Auto for automated AAV capsid analysis
New mass photometer characterises AAV sample purity and empty/full ratio, with less manual operation time and greater reproducibility
Subscribe now